Literature DB >> 25421801

Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization.

Hongdo Do1, Alexander Dobrovic1.   

Abstract

BACKGROUND: Precision medicine is dependent on identifying actionable mutations in tumors. Accurate detection of mutations is often problematic in formalin-fixed paraffin-embedded (FFPE) tissues. DNA extracted from formalin-fixed tissues is fragmented and also contains DNA lesions that are the sources of sequence artifacts. Sequence artifacts can be difficult to distinguish from true mutations, especially in the context of tumor heterogeneity, and are an increasing interpretive problem in this era of massively parallel sequencing. Understanding of the sources of sequence artifacts in FFPE tissues and implementation of preventative strategies are critical to improve the accurate detection of actionable mutations. CONTENT: This mini-review focuses on DNA template lesions in FFPE tissues as the source of sequence artifacts in molecular analysis. In particular, fragmentation, base modification (including uracil and thymine deriving from cytosine deamination), and abasic sites are discussed as indirect or direct sources of sequence artifacts. We discuss strategies that can be implemented to minimize sequence artifacts and to distinguish true mutations from sequence artifacts. These strategies are applicable for the detection of actionable mutations in both single amplicon and massively parallel amplicon sequencing approaches.
SUMMARY: Because FFPE tissues are usually the only available material for DNA analysis, it is important to maximize the accurate informational content from FFPE DNA. Careful consideration of each step in the work flow is needed to minimize sequence artifacts. In addition, validation of actionable mutations either by appropriate experimental design or by orthogonal methods should be considered.
© 2014 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25421801     DOI: 10.1373/clinchem.2014.223040

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  159 in total

Review 1.  Methods of measurement for tumor mutational burden in tumor tissue.

Authors:  Bárbara Meléndez; Claude Van Campenhout; Sandrine Rorive; Myriam Remmelink; Isabelle Salmon; Nicky D'Haene
Journal:  Transl Lung Cancer Res       Date:  2018-12

2.  Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.

Authors:  Yajian Wang; Haijing Liu; Yingyong Hou; Xiaoyan Zhou; Li Liang; Zhihong Zhang; Huaiyin Shi; Sanpeng Xu; Peizhen Hu; Zuyu Zheng; Rui Liu; Tingdong Tang; Feng Ye; Zhiyong Liang; Hong Bu
Journal:  Virchows Arch       Date:  2018-04-28       Impact factor: 4.064

3.  Formalin-fixed paraffin-embedded sample conditions for deep next generation sequencing.

Authors:  Masayuki Nagahashi; Yoshifumi Shimada; Hiroshi Ichikawa; Satoru Nakagawa; Nobuaki Sato; Koji Kaneko; Keiichi Homma; Takashi Kawasaki; Keisuke Kodama; Stephen Lyle; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Surg Res       Date:  2017-07-27       Impact factor: 2.192

4.  Non-reproducible sequence artifacts in FFPE tissue: an experience report.

Authors:  Richard Ofner; Cathrin Ritter; Selma Ugurel; Lorenzo Cerroni; Mathias Stiller; Thomas Bogenrieder; Flavio Solca; David Schrama; Jürgen C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-17       Impact factor: 4.553

5.  Generating Exome Enriched Sequencing Libraries from Formalin-Fixed, Paraffin-Embedded Tissue DNA for Next-Generation Sequencing.

Authors:  Beth A Marosy; Brian D Craig; Kurt N Hetrick; P Dane Witmer; Hua Ling; Sean M Griffith; Benjamin Myers; Elaine A Ostrander; Janet L Stanford; Lawrence C Brody; Kimberly F Doheny
Journal:  Curr Protoc Hum Genet       Date:  2017-01-11

Review 6.  Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS.

Authors:  Xiaomin Niu; Jody C Chuang; Gerald J Berry; Heather A Wakelee
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

7.  Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel Assay.

Authors:  Pham Nguyen Quy; Masashi Kanai; Keita Fukuyama; Tadayuki Kou; Tomohiro Kondo; Yoshihiro Yamamoto; Junichi Matsubara; Akinori Hiroshima; Hiroaki Mochizuki; Tomohiro Sakuma; Mayumi Kamada; Masahiko Nakatsui; Yuji Eso; Hiroshi Seno; Toshihiko Masui; Kyoichi Takaori; Sachiko Minamiguchi; Shigemi Matsumoto; Manabu Muto
Journal:  Oncologist       Date:  2019-06-11

Review 8.  Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory.

Authors:  José Luis García-Giménez; Marta Seco-Cervera; Trygve O Tollefsbol; Carlos Romá-Mateo; Lorena Peiró-Chova; Pablo Lapunzina; Federico V Pallardó
Journal:  Crit Rev Clin Lab Sci       Date:  2017-12-11       Impact factor: 6.250

Review 9.  Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations.

Authors:  Jesse J Salk; Michael W Schmitt; Lawrence A Loeb
Journal:  Nat Rev Genet       Date:  2018-03-26       Impact factor: 53.242

10.  Method for preservation of DNA stability of liquid-based cytology specimens from a lung adenocarcinoma cell line.

Authors:  Yukiko Matsuo; Kazuya Yamashita; Tsutomu Yoshida; Yukitoshi Satoh
Journal:  Virchows Arch       Date:  2020-08-31       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.